PRESS -PAR: Early Detection and PREvention of Symptomatic postSurgical hypoPARathyroidism After Thyroid Surgery"

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorNicolas Schlegel

About this trial

This study aims to investigate whether an earlier measurement of parathyroid hormone can reduce the number of patients who develop symptomatic hypoparathyroidism. This will provide evidence for a clear algorithm to address this issue after thyroid surgery. It will lead to an improvement in quality of life and a reduction in the distress experienced by affected patients. In addition, it is conceivable that patients' hospital stay could be shortened.

Eligibility criteria

Qualifiers

Age ≥ 18 years

Thyroidectomy or bilateral thyroid resection of any indication

Written informed consent obtained after detailed patient information and provision of an information sheet

Disqualifiers

Age ≤ 18 years

Concomitant parathyroid disease (primary or secondary hyperparathyroidism, pre-existing hypoparathyroidism of any cause)

Previous surgery in the neck region

Pregnancy or breastfeeding

Trial design

Treatments tested in this trial

  • Active vitamin D
  • Calcium

Treatment groups

336 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Nicolas Schlegel

Lead sponsor

University of Wuerzburg

Sponsor institution

University of Wuerzburg

Collaborator